Erik Greb
News
Intensive blood pressure lowering may not reduce risk of recurrent stroke
March 20, 2019
HONOLULU – Intensive treatment significantly reduces blood pressure, compared with standard treatment, and is equally safe.
![1]()
News
Andexanet alfa effectively reverses factor Xa inhibition
March 18, 2019
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated with factor Xa inhibition.
News
Glyceryl trinitrate does not improve outcomes of ischemic stroke
March 7, 2019
HONOLULU – Although treatment reduced blood pressure, it did not reduce disability at 90 days, compared with sham.
![1]()
News
Deferoxamine does not improve 90-day outcomes after ICH
February 14, 2019
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
![1]()
News
Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke
February 7, 2019
HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.
News
Benefit of thrombectomy may be universal
January 28, 2019
The proportional benefit of thrombectomy is uniform among various subgroups of patients with acute ischemic stroke.
News
AAN publishes position statement on brain death
January 8, 2019
The association calls for uniform laws and policies regarding brain death, as well as continued research and public education.
